Skip to content

To evaluate the Safety and efficacy of two Unani formulations in the treatment of overactive bladder.

Validation of Unani Pharmacopoeial formulations in Zof-e-Masana (Overactive Bladder)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004258
Enrollment
300
Registered
2013-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N329- Bladder disorder, unspecified Health Condition 2: null- Zof-e-Masana (Overactive Bladder)

Interventions

Intervention1: 1. Majoon Flasfa 2. Majoon Masik ul baul : 1. Majoon Filasfa, 7 gm orally in the morning 2. Majoon Masikul Baul 7 gm orally in the morning. Duration of therapy is 12 weeks All the med

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age- more than 18 yrs and upto 65 yrs 2. Gender- both 3. History of the following symptoms for more than six months • Urgency of urine • Incontinence • Dysuria

Exclusion criteria

Exclusion criteria: Patients with Bladder calculus 2. Patients withUrinary tract infections 3. Patients with Benign Prostrate Hypertrophy 4. Patients with Uterine prolapse 5. Patients with Rectocele/cystocele 6. Patients with Cystitis 7. Patients with Diabetes Mellitus 8. Patients with Hypertension 9. Pregnant and lactating females 10. Neoplasm 11. Patients with Hepatic/Cardiac diseases 12. Medications (anticholinergic, antidepressant, psychotropic, or alpha-blocker) 13. Patients with History of any Spinal cord injury

Design outcomes

Primary

MeasureTime frame
Improvements in signs and symptoms of Hypertension Timepoint: 12WEEKS

Secondary

MeasureTime frame
Hematological and biochemical assessments for safety Timepoint: 12 WEEKS

Countries

India

Contacts

Public ContactDR ABDUL HANNAN

Central Council for Research in Unani Medicine (CCRUM),

ccrum605@gmail.com011-28521981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026